# A Trial of Neuroprotection With ACTH in Acute Optic Neuritis

> **NCT01838174** · PHASE4 · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 37 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** ACTHAR Gel (ACTH)
- **DRUG:** IV methylprednisolone (steroids)

## Key facts

- **NCT ID:** NCT01838174
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2022-01-13
- **Final completion:** 2022-01-13
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Sponsor requested
- **Last updated:** 2023-04-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01838174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01838174, "A Trial of Neuroprotection With ACTH in Acute Optic Neuritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01838174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*